{
    "paper_id": "700c450ea0a96179202c2b08922e502fc7533fe5",
    "metadata": {
        "title": "PROGNOSTIC FACTORS FOR CLINICAL COURSE OF PATIENTS WITH COVID-19: PROTOCOL FOR A RAPID LIVING SYSTEMATIC REVIEW",
        "authors": [
            {
                "first": "C\u00e9sar",
                "middle": [],
                "last": "Ramos Rocha-Filho",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ana",
                "middle": [],
                "last": "Carolina",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Pereira",
                "middle": [],
                "last": "Nunes",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Pinto",
                "middle": [],
                "last": "Ii",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Aline",
                "middle": [],
                "last": "Pereira",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Rocha",
                "middle": [],
                "last": "Iii",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Keilla",
                "middle": [],
                "last": "Martins",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Milby",
                "middle": [],
                "last": "Iv",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Felipe",
                "middle": [],
                "last": "Sebasti\u00e3o",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Assis",
                "middle": [],
                "last": "Reis",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Vinicius",
                "middle": [],
                "last": "Tassoni",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Civile",
                "middle": [],
                "last": "Vi",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Nelson",
                "middle": [],
                "last": "Carvas",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Junior",
                "middle": [],
                "last": "Vii",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Rodolfo",
                "middle": [
                    "Rodrigo"
                ],
                "last": "Pereira",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Santos",
                "middle": [],
                "last": "Viii",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Gabriel",
                "middle": [],
                "last": "Sodr\u00e9",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ramalho",
                "middle": [],
                "last": "Ix",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Giulia",
                "middle": [],
                "last": "Fernandes",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Mo\u00e7a",
                "middle": [],
                "last": "Trevisani",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Laura",
                "middle": [],
                "last": "Jantsch",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ferla",
                "middle": [],
                "last": "Xi",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Maria",
                "middle": [],
                "last": "Eduarda",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Puga",
                "middle": [],
                "last": "Santos",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Virg\u00ednia",
                "middle": [],
                "last": "Xii",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Mo\u00e7a",
                "middle": [],
                "last": "Fernandes",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Xiii",
                "middle": [],
                "last": "Trevisani",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Corresponding",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Alvaro",
                "middle": [],
                "last": "Nagib",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Atallah",
                "middle": [],
                "last": "Xiv",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Since the first report issued by the World Health Organization (WHO) in early December 2019, the Coronavirus Disease 2019 (COVID-19) outbreak has escalated rapidly (1). Up to April 29, 2020, more than 3 million cases of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection had been reported from 210 countries and territories; more than 200 thousand people had died (2) .",
            "cite_spans": [
                {
                    "start": 384,
                    "end": 387,
                    "text": "(2)",
                    "ref_id": "BIBREF1"
                }
            ],
            "ref_spans": [],
            "section": "INTRODUCTION"
        },
        {
            "text": "In the scenario of a Public Health Emergency of International Concern, the spectrum of illness presentation or its severity profile is one of the most important parameters for an effective decision-making (3) . It helps medical staff during the assessment of patients when the allocation of limited healthcare resources is a reality. It also helps within the effort to provide the best possible care for patients while ensuring the sustainability of the health system (1, 3) .",
            "cite_spans": [
                {
                    "start": 205,
                    "end": 208,
                    "text": "(3)",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 472,
                    "end": 474,
                    "text": "3)",
                    "ref_id": "BIBREF2"
                }
            ],
            "ref_spans": [],
            "section": "INTRODUCTION"
        },
        {
            "text": "Prognostic factors are known as good indicators to predict disease progression and severity level (3) . Currently, it is well established that the case fatality rate for SARS-CoV-2 infection increases with age and number of comorbidities (1). Other factors, such as the decline of the immune function (4), proinflammatory profile (5) and alterations in the Angiotensin I Converting Enzyme 2 (ACE2) (4) are also being described by relevant clinical reports as predictors for COVID-19 progression.",
            "cite_spans": [
                {
                    "start": 98,
                    "end": 101,
                    "text": "(3)",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 330,
                    "end": 333,
                    "text": "(5)",
                    "ref_id": "BIBREF4"
                }
            ],
            "ref_spans": [],
            "section": "INTRODUCTION"
        },
        {
            "text": "Despite the promising data, to the best of our knowledge the predictive capacity and reliability of these potential indicators has not been properly clarified yet. Thus, the purpose of this rapid living systematic review is to identify the evidence about prognostic factors in patients with COVID-19, considering the following research questions: ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "INTRODUCTION"
        },
        {
            "text": "The protocol of this systematic review was registred in the Prospective Register of Systematic Reviews (PROSPERO) platform (CRD42020183437). To conduct the rapid living systematic review, we will employ abbreviated systematic review methods. Compared with the methods of a systematic review, the review team will apply the following methodological shortcuts (6):",
            "cite_spans": [],
            "ref_spans": [],
            "section": "METHODS"
        },
        {
            "text": "no specific searches of grey literature;",
            "cite_spans": [],
            "ref_spans": [],
            "section": "METHODS"
        },
        {
            "text": "no independent screen of abstracts.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "METHODS"
        },
        {
            "text": "Types of studies",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Eligibility Criteria"
        },
        {
            "text": "We will include prospective and retrospective longitudinal cohorts. In view of the limited amount of information, we will also include case control studies. We will not include cross sectional studies, as it is not possible to determine prognosis from this design.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Eligibility Criteria"
        },
        {
            "text": "We will include studies that have evaluated patients with confirmed diagnosis of infection of SARS-CoV-2.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Types of participants"
        },
        {
            "text": "We will include studies performed since November 2019. No language restrictions will be used in the selection.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Report characteristics"
        },
        {
            "text": "We will search MEDLINE via PubMed, EMBASE via Elsevier, Cochrane Library -Cochrane Central Register of Controlled Trials (CENTRAL), Scopus, Portal Regional BVS -LILACS, and",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Data Sources and Searches"
        },
        {
            "text": "Webof Science, using relevant descriptors and synonyms, adapting the search to the requirements of each database. We will also search in the World Health Organization",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Data Sources and Searches"
        },
        {
            "text": "International Clinical Trials Registry Platform (WHO ICTRP) and ClinicalTrials.gov aiming to . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Data Sources and Searches"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 9, 2020. . https://doi.org/10.1101/2020.05.06.20087692 doi: medRxiv preprint identify published, ongoing, and unpublished studies. Finally, we will use the technique of snowballing, searching the lists of references of the included studies.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Data Sources and Searches"
        },
        {
            "text": "We will use the terms related to the problem of interest and the filter for prognostic studies provided by Wilczynski and Haynes (8) . The search strategy in MEDLINE via Pubmed is shown in Table 1 . The search strategy above will be used in Medline via Pubmed and will be adapted to the specifications of each database.",
            "cite_spans": [
                {
                    "start": 107,
                    "end": 132,
                    "text": "Wilczynski and Haynes (8)",
                    "ref_id": null
                }
            ],
            "ref_spans": [
                {
                    "start": 189,
                    "end": 196,
                    "text": "Table 1",
                    "ref_id": "TABREF1"
                }
            ],
            "section": "Search Strategy"
        },
        {
            "text": "Based on pre-specified eligibility criteria, two authors will select the studies for inclusion in the review (KMM and ACPNP). When duplicated studies are found in more than one database (studies using the same participants and different outcome measurements or using different time points for the assessments), both reports will be included, but the two reports will be considered as parts of only one study. When duplicated reports are found, e.g. studies with the same participants, with the same outcome measurements and using the same time points for the assessments, the report with the smaller sample size will be excluded. After removing duplicate studies and reports, the authors will read the study titles and abstracts. Studies that clearly do not match the inclusion criteria for the review will be excluded. The selected studies . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Study Selection"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 9, 2020. . will then be fully read for further scrutiny. The reasons for exclusion of the studies that are fully read will be presented. Disagreements between authors regarding study inclusion will be resolved by the third author (APR). To optimize the process of screening and selection of studies, we will use Rayyan application (9) .",
            "cite_spans": [
                {
                    "start": 394,
                    "end": 397,
                    "text": "(9)",
                    "ref_id": "BIBREF9"
                }
            ],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "Two authors (ACPNP and CRRF) will independently extract data. Discrepancies or disagreements will be solved by a third author (APR). A predefined form will be used to extract data from included studies. The form will include the following information: (i) the patients To assess the feasibility of performing a meta-analysis, we will also extract data for each primary and secondary outcome measure: (i) total number of patients (in each group); (ii) number of events in each group (for dichotomous outcomes);(iii) mean, standard deviation, standard error, median, interquartile range, minimum, maximum, 95% confidence interval (CI) (for continuous outcomes); (iv) p value; (v) hazard ratios with their respective standard errors or confidence intervals (95%).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Data Extraction and management"
        },
        {
            "text": "We will perform critical appraisal of included studies with Quality in Prognosis Studies (QUIPS) (10) scale as recommended by Cochrane Collaboration. We will evaluate the certainty of evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) (11) . GRADE judgement is based on the overall risk of bias, consistency of the . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [
                {
                    "start": 277,
                    "end": 281,
                    "text": "(11)",
                    "ref_id": "BIBREF11"
                }
            ],
            "ref_spans": [],
            "section": "Assessment of Methodological Quality in included studies and certainty of evidence"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 9, 2020. . https://doi.org/10.1101/2020.05.06.20087692 doi: medRxiv preprint results, directness of the evidence, publication bias and precision of the results for each outcome. The GRADE profiler software, available online, will be used to summarize our findings on the quality of evidence (12) . Assessment of risk of bias (ACPNP and APR), and assessment of the quality of evidence (VTC and NCJ) will be performed by two review authors.",
            "cite_spans": [
                {
                    "start": 354,
                    "end": 358,
                    "text": "(12)",
                    "ref_id": "BIBREF12"
                }
            ],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "All the disagreements in the assessment of the risk of bias or quality of evidence will be solved through discussion or, if required, by consulting with a third author (ANA).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "We will perform analyses according to the recommendations of Cochrane, and the Cochrane Prognosis Methods Group, and we will use Review Manager 5 to perform meta-analysis when possible for hazard or odds ratios.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Data Synthesis and Analysis"
        },
        {
            "text": "We will pool hazard ratios (unadjusted (crude) or adjusted) or odds ratio with their standard errors for hospital admission, intensive care unit admission and/or respiratory support for adult inpatients with COVID-19 and mortality, using generic inverse variance method with randomeffects model.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Data Synthesis and Analysis"
        },
        {
            "text": "We will also pool incidence results (for prognostic factors) with their respective confidence intervals (95%) by the inverse variance method with a random-effects model, using the DerSimonian-Laird estimator for \u03c4 2. We will adjust data by Freeman-Tukey double arcosen transformation and confidence intervals will be calculate by the Clopper-Pearson method for individual studies. For these data, we will perform proportion meta-analysis using RStudio \u00a9 software, with the \"meta\" package (version 4.9-6) and \"metaprop\" function.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Data Synthesis and Analysis"
        },
        {
            "text": "For studies that do not provide an HR and associated standard error (SE), we will use information and results reported in the text, tables, and Kaplan-Meier (K-M) curves.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Dealing with missing data"
        },
        {
            "text": "We will contact the principal investigators of included studies asking for additional data, or to clarify issues regarding the studies. In the absence of a reply from the authors, we will expose the data in a descriptive manner avoiding imputation.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Dealing with missing data"
        },
        {
            "text": ". CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Dealing with missing data"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 9, 2020. . https://doi.org/10.1101/2020.05.06.20087692 doi: medRxiv preprint",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "We will employ the Cochran's Q test to assess the presence of heterogeneity considering a threshold of P value < 0.1 as an indicator of whether heterogeneity is present.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Assessment of heterogeneity"
        },
        {
            "text": "In addition, we will assess statistical heterogeneity by examining the Higgins I 2 statistic following these thresholds: ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Assessment of heterogeneity"
        },
        {
            "text": "This rapid living review will systematically evaluate the best available evidence to identify the risk and protective factors of COVID-19, which we expect will help the front line on their decision making processes. While some data (13) have shown older adults are at higher risk for worse outcomes, other studies have raised additional questions on whether factors such as the decline in immune function (4), proinflammatory profile (5) and alterations on the angiotensin I converting enzyme 2 (ACE2) (4) could also constitute risk factors for worse outcomes. At the same time, our review aims to clarify the uncertainty over which characteristics could constitute protective factors once a person has been exposed to SARS-",
            "cite_spans": [
                {
                    "start": 232,
                    "end": 236,
                    "text": "(13)",
                    "ref_id": "BIBREF13"
                }
            ],
            "ref_spans": [],
            "section": "DISCUSSION"
        },
        {
            "text": "To ensure the quality of the results, we will follow the Cochrane Handbook of Systematic Reviews recommendations (7) . If possible, we plan to pool data into meta-analysis for reducing the probability of type 2 error within the comparisons. Potential limitations for this study include the possibility of finding biased studies which can make them unsuitable for clustering or metaanalysis, or small sample studies that do not allow us to provide precise estimates.",
            "cite_spans": [
                {
                    "start": 113,
                    "end": 116,
                    "text": "(7)",
                    "ref_id": "BIBREF7"
                }
            ],
            "ref_spans": [],
            "section": "DISCUSSION"
        },
        {
            "text": "We believe that the strengths of this rapid systematic review include the transparency, the strict methods, the evaluation of the quality of evidence, and the extensive and more sensitive searches. This being said, we will be able to identify the current available evidence, differentiating the prognostic factors for each stage of the disease and to provide important . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "DISCUSSION"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 9, 2020. . https://doi.org/10.1101/2020.05.06.20087692 doi: medRxiv preprint information for clinical decision-making on coronavirus disease 2019 (COVID-19) that has recently emerged and caused a deadly pandemic.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "This systematic review protocol was written as per the PRISMA-P guidelines (14). . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Reporting standards"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 9, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 9, 2020. . https://doi.org/10.1101/2020.05.06.20087692 doi: medRxiv preprint",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Coronavirus disease 2019 (COVID-19) BMJ Best Practice",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "J"
                    ],
                    "last": "Beeching",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "E"
                    ],
                    "last": "Fletcher",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Fowler",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "World Health Organization. Coronavirus disease 2019 (COVID-19)",
            "authors": [],
            "year": null,
            "venue": "Situation Report",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "T"
                    ],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Leung",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bushman",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kishore",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Niehus",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "M"
                    ],
                    "last": "De Salazar",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nature Medicine",
            "volume": "26",
            "issn": "4",
            "pages": "506--516",
            "other_ids": {
                "DOI": [
                    "10.1038/s41591-020-0822-7"
                ]
            }
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "COVID-19 and Older Adult",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "E"
                    ],
                    "last": "Morley",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Vellas",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Nutr Health Aging",
            "volume": "24",
            "issn": "",
            "pages": "364--365",
            "other_ids": {
                "DOI": [
                    "10.1007/s12603-020-1349-9"
                ]
            }
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "The reality of getting old",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "G"
                    ],
                    "last": "Lakatta",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Nat Rev Cardiol",
            "volume": "15",
            "issn": "9",
            "pages": "499--500",
            "other_ids": {
                "DOI": [
                    "10.1038/s41569-018-0068-y"
                ]
            }
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Cochrane Rapid Reviews Interim Guidance from the Cochrane Rapid Reviews Methods Group 2020",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Cochrane Handbook for Systematic Reviews of Interventions",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Higgins",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Developing optimal search strategies for detecting clinically sound prognostic studies in MEDLINE: an analytic survey",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "L"
                    ],
                    "last": "Wilczynski",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "B"
                    ],
                    "last": "Haynes",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "For The Hedges",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Team",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "BMC Med",
            "volume": "2",
            "issn": "1",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Rayyan-a web and mobile app for systematic reviews",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ouzzani",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Hammady",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Fedorowicz",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Elmagarmid",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Syst Rev",
            "volume": "5",
            "issn": "1",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1186/s13643-016-0384-4"
                ]
            }
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Assessing Bias in Studies of Prognostic Factors",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Hayden",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Van Der Windt",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cartwright",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "C\u00f4t\u00e9",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Bombardier",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Annals of internal medicine",
            "volume": "158",
            "issn": "",
            "pages": "280--286",
            "other_ids": {
                "DOI": [
                    "10.7326/0003-4819-158-4-201302190-00009"
                ]
            }
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Grading quality of evidence and strength of recommendations",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Atkins",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Best",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "A"
                    ],
                    "last": "Briss",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Eccles",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Falck-Ytter",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Flottorp",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Bmj",
            "volume": "328",
            "issn": "7454",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1136/bmj.328.7454.1490"
                ]
            }
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Grade's software for summary of findings tables, health technology assessment and guidelines",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Gdt G",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "OR (Epidemia de Pneumonia por Coronav\u00edrus em Wuhan) OR (Epidemia de Pneumonia por Coronav\u00edrus em Wuhan de 2019-2020) OR (Epidemia de Pneumonia por Novo Coronav\u00edrus de 2019-2020) OR (Epidemia pelo Coronav\u00edrus de Wuhan) OR (Epidemia pelo Coronav\u00edrus em Wuhan) OR (Epidemia pelo Novo Coronav\u00edrus (2019-nCoV)) OR (Epidemia pelo Novo Coronav\u00edrus 2019) OR (Epidemia por 2019-nCoV) OR (Epidemia por Coronav\u00edrus de Wuhan) OR (Epidemia por Coronav\u00edrus em Wuhan) OR (Epidemia por Novo Coronav\u00edrus (2019-nCoV)) OR (Epidemia por Novo Coronav\u00edrus 2019) OR (Febre de Pneumonia por Coronav\u00edrus de Wuhan) OR (Infec\u00e7\u00e3o pelo Coronav\u00edrus 2019-nCoV) OR (Infec\u00e7\u00e3o pelo Coronav\u00edrus de Wuhan) OR (Infec\u00e7\u00e3o por Coronavirus 2019-nCoV) OR (Infec\u00e7\u00e3o por Coronav\u00edrus 2019-nCoV) OR (Infec\u00e7\u00e3o por Coronav\u00edrus de Wuhan) OR (Infec\u00e7\u00f5es por Coronav\u00edrus) OR (Pneumonia do Mercado de Frutos do Mar de Wuhan) OR (Pneumonia no Mercado de Frutos do Mar de Wuhan) OR (Pneumonia por Coronav\u00edrus de Wuhan) OR (Pneumonia por Novo Coronav\u00edrus de",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Mcgoogan",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "OR (Surto pelo Novo Coronav\u00edrus (2019-nCoV)) OR (Surto pelo Novo Coronav\u00edrus 2019) OR (Surto por 2019-nCoV) OR (Surto por Coronav\u00edrus 2019-nCoV) OR (Surto por Coronav\u00edrus de Wuhan) OR (Surto por Coronav\u00edrus de Wuhan de 2019-2020) OR (Surto por Novo Coronav\u00edrus (2019-nCoV)) OR (Surto por Novo Coronav\u00edrus 2019) OR (S\u00edndrome Respirat\u00f3ria do Oriente M\u00e9dio) OR (S\u00edndrome Respirat\u00f3ria do Oriente M\u00e9dio (MERS)) OR (S\u00edndrome Respirat\u00f3ria do Oriente M\u00e9dio (MERS-CoV)) OR (S\u00edndrome Respirat\u00f3ria do Oriente M\u00e9dio por Coronav\u00edrus) OR MH:C01",
            "authors": [],
            "year": 2019,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "corona virus*) OR (Coronavirus (COVID-19)) OR (2019 novel coronavirus disease) OR (COVID-19 pandemic) OR (COVID-19 virus infection) OR (coronavirus disease-19) OR (2019 novel coronavirus infection) OR (2019-nCoV infection) OR (coronavirus disease 2019) OR (2019-nCoV disease) OR (COVID-19 virus disease) OR (severe acute respiratory syndrome coronavirus 2) OR (Wuhan coronavirus) OR (Wuhan seafood market pneumonia virus) OR (COVID19 virus) OR (COVID-19 virus) OR (coronavirus disease 2019 virus) OR",
            "authors": [],
            "year": 2019,
            "venue": "#5 (COVID 19) OR (COVID-19) OR (2019-nCoV) OR (nCoV) OR (Covid19) OR (SARS-CoV) OR (SARSCov2 or ncov*) OR (SARSCov2) OR (2019 coronavirus*) OR",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "corona virus*) OR (Coronavirus (COVID-19)) OR (2019 novel coronavirus disease) OR (COVID-19 pandemic) OR (COVID-19 virus infection) OR (coronavirus disease-19) OR (2019 novel coronavirus infection) OR (2019-nCoV infection) OR (coronavirus disease 2019) OR (2019-nCoV disease) OR (COVID-19 virus disease) OR (severe acute respiratory syndrome coronavirus 2) OR (Wuhan coronavirus) OR (Wuhan seafood market pneumonia virus) OR (COVID19 virus) OR (COVID-19 virus) OR (coronavirus disease 2019 virus) OR",
            "authors": [],
            "year": 2019,
            "venue": "#1 (COVID 19) OR (COVID-19) OR (2019-nCoV) OR (nCoV) OR (Covid19) OR (SARS-CoV) OR (SARSCov2 or ncov*) OR (SARSCov2) OR (2019 coronavirus*) OR",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "demographic and clinical characteristics); (ii) setting; (iii) time points used for the assessments; (iv) -number of patients lost to follow-up (in each group); (v) reasons for loss to follow up; (vi) -interventions being received; (vii) approach for handling missing data (data imputation/how data imputation was performed, use of intention-to-treat approach); (viii) sources of funding; (ix) possibility of conflict of interests; (x) adverse events; (xi) outcome measures; (xii) protocol deviations.",
            "latex": null,
            "type": "figure"
        },
        "TABREF1": {
            "text": "Systematic review Search Strategy MeSH:noexp] OR mortality[MeSH Terms] OR follow up studies[MeSH:noexp] OR prognos*[Text Word] OR predict*[Text Word] OR course*[Text Word])",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": ". https://doi.org/10.1101/2020.05.#1 MeSH descriptor: [Coronavirus] explode all trees #2 MeSH descriptor: [Coronaviridae] explode all trees #3 MeSH descriptor: [Betacoronavirus] explode all trees #4 MeSH descriptor: [Coronavirus Infections] explode all trees #5 (COVID 19) OR (COVID-19) OR(2019-nCoV) OR (nCoV) OR (Covid19) OR (SARS-CoV) OR (SARSCov2 or ncov*) OR (SARSCov2) OR (2019 coronavirus*) OR (2019 corona virus*) OR (Coronavirus (COVID-19)) OR (2019 novel coronavirus disease) OR (COVID-19 pandemic) OR (COVID-19 virus infection) OR (coronavirus disease-19) OR (2019 novel coronavirus infection) OR (2019-nCoV infection) OR (coronavirus disease 2019) OR (2019-nCoV disease) OR (COVID-19 virus disease) OR \"severe acute respiratory syndrome coronavirus 2\" [Supplementary Concept] OR (Wuhan coronavirus) OR (Wuhan seafood market pneumonia virus) OR (COVID19 virus) OR (COVID-19 virus) OR (coronavirus disease 2019 virus) OR (SARS-CoV-2) OR (SARS2) OR (2019-nCoV) OR (2019 novel coronavirus) #6 #1 OR #2 OR #3 OR #4 OR #5 EMBASE #1 'covid 19'/exp OR (COVID 19) OR (COVID-19) OR (2019-nCoV) OR (nCoV) OR (Covid19) OR (SARS-CoV) OR (SARSCov2 or ncov*) OR (SARSCov2) OR (2019 coronavirus*) OR (2019 corona virus*) OR (Coronavirus (COVID-19)) OR (2019 novel coronavirus disease) OR (COVID-19 pandemic) OR (COVID-19 virus infection) OR (coronavirus disease-19) OR (2019 novel coronavirus infection) OR (2019-nCoV infection) OR (coronavirus disease 2019) OR (2019-nCoV disease) OR (COVID-19 virus disease) OR (severe acute respiratory syndrome coronavirus 2) OR (Wuhan coronavirus) OR (Wuhan seafood market pneumonia virus) OR (COVID19 virus) OR (COVID-19 virus) OR (coronavirus disease 2019 virus) OR (SARS-CoV-2) OR (SARS2) OR (2019-nCoV) OR (2019 novel coronavirus) #2 #1 AND [embase]/lim NOT ([embase]/lim AND [medline]/lim) PORTAL REGIONAL BVS -LILACSMH:\"Infec\u00e7\u00f5es por Coronavirus\" OR (Infec\u00e7\u00f5es por Coronavirus) OR (Infecciones por Coronavirus) OR (Coronavirus Infections) OR (COVID-19) OR (COVID 19) OR (Doen\u00e7a pelo Novo Coronav\u00edrus (2019-nCoV)) OR (Doen\u00e7a por Coronav\u00edrus 2019-nCoV) OR (Doen\u00e7a por Novo Coronav\u00edrus (2019-nCoV)) OR (Epidemia de Pneumonia por Coronavirus de Wuhan) OR (Epidemia de Pneumonia por Coronav\u00edrus de Wuhan) OR (Epidemia de Pneumonia por Coronav\u00edrus de Wuhan de . CC-BY-NC 4.0 International license It is made available under a",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}